O’Melveny Worldwide

Carl Erik Heiberg is an established corporate transactional lawyer specializing in mergers and acquisitions, foreign direct investments into China, fund formation, private equity investments, and international anti-corruption investigations and compliance. Prior to joining O’Melveny, Carl clerked for a New York State Supreme Court Justice for two years. Additionally, he worked in the Shanghai office of another law firm for approximately four years before attending law school.

  • A Swiss elevator company in the acquisition of its partners’ interests in its China joint ventures
  • A public U.S. radiation therapy company in its joint venture with a Chinese State-owned enterprise
  • A U.S.-based food technology company in several acquisitions throughout the United States and globally
  • A China/Hong Kong dual listed R&D service provider for the life sciences industry in multiple acquisitions of U.S. and U.K. companies
  • An American media and entertainment company in its joint venture and related licensing matters with a Chinese entertainment, media and internet company to distribute foreign motion pictures in China via the internet
  • A U.S. information technology, product and services company in its joint venture with a Chinese electronics company to bring online meeting and videoconferencing applications to the Chinese market
  • A U.S. IT services and consulting company in its multi-jurisdictional acquisition of the LED business lines of a semiconductor manufacturer
  • One of the world’s leading executive coaching companies on the disposition of its China assets and the license of its brand to the Chinese buyer
  • A Chinese listed company in its $272.5 million acquisition of Florida-based diabetes products testing company and its $110 million acquisition of an Indiana-based diagnostics products company
  • The founders of a leading Chinese wine, spirit and beverage importation and distribution company in the divestiture of their business to an Australian liquor company
  • The founders of a clinical laboratory operator providing diagnostic testing for doctors, hospitals and pharmaceutical firms throughout China in the sale of a majority interest in the company and advice related to its subsequent listing in Hong Kong
  • A Chinese pharmaceutical and dyestuffs company in its planned acquisition of the textile effects business of a global manufacturer and marketer of differentiated chemicals
  • A consortium comprised of a Chinese listed company and China-based funds in their bid to acquire one of the world’s largest vitamin and nutritional supplement companies
  • A consortium comprised of a Chinese listed company and U.S. and China-based funds in their bid to acquire a U.S. sports marketing company
  • A U.S.-based biomass-to-fuel conversion company in their contemplated China joint venture and related licensing matters
  • A U.S. Fortune 500 global technology and specialty materials company on the China-related aspects of a global acquisition and its contemplated joint venture with a Chinese partner
  • A U.S. automotive company on its China-based manufacturing joint venture with another U.S. auto parts manufacturer
  • A Taiwan-based biomaterials engineering company in its acquisition by a U.S.-listed life sciences company
  • A Chinese CRO for medical technology in its acquisition of a U.S. licensing consulting firm
  • A CRO operating in Mainland China and Taiwan in its sale to a consortium led by a Boston-based private equity fund
  • A leading Chinese genomics company in multiple outbound investments and related licensing matters
  • A U.S.-based pharmaceutical contract services company on its offshore joint venture with a China-based pharmaceutical contract research company, the joint venture’s establishment of a wholly-owned China subsidiary, and the client’s subsequent buyout of its joint venture partner
  • One of the world’s largest fragrance corporations in acquiring a leading Chinese skin care company
  • A U.S. Fortune 500 company on multiple joint ventures, acquisitions and strategic alliances in China with State-owned enterprises and private Chinese companies, as well as related licenses of its intellectual property
  • A global investment banking and management firm on the divestiture of some of its China investments
  • A U.S.-based business intelligence software company on multiple matters, including the formation and liquidation of its China entities, employment and licensing matters, and the sale of assets and transfer of employees in China as part of a worldwide spin-off of one of its business lines
  • A U.S. publicly listed Chinese R&D outsourcing company for global pharmaceutical companies in its planned acquisition by a U.S. publicly listed American drug R&D company
  • A national pension fund in several anchor investments in Asia-based funds
  • A German company in the license of its water sewage treatment technology to a Chinese company
  • A German semiconductor company on the distressed sale of its interests in a Chinese wholly-owned subsidiary and a Sino-foreign joint venture company
  • Multiple private equity funds on their investments into Chinese companies and related matters
  • Several U.S. listed companies in internal investigations and in developing their internal anticorruption compliance policies and procedures

Languages

  • Mandarin Chinese

Admissions

Bar Admissions

  • New York

Education

  • University of Minnesota, J.D.: cum laude
  • The Johns Hopkins University - Nanjing University Center for Chinese and American Studies, Certificate, International Relations
  • Swarthmore College, B.A., Economics and Chinese Studies

Professional Activities

Law Clerk

  • Honorable Jane S. Solomon, New York State Supreme Court

Author

  • Practice Note, “Due diligence process in China acquisitions,” Practical Law China (2018)
  • Practice Note, “Due diligence process in China acquisitions,” Practical Law China (2014)
  • Note, “American Films in China: An Analysis of China's Intellectual Property Record and Reconsideration of Cultural Trade Exceptions Amidst Rampant Piracy,” 15 Minn.J.Int'l L.219 (2006)

Co-Author

  • “China Tightens Restrictions on Foreign Representative Offices,” the China Business Review (September-October 2010)
  • “Ministry of Culture Issues Comprehensive Regulation on Online Games,” Asia IP (September 2009)

Articles Editor

  • Minnesota Journal of International Law

Teacher

  • Brooklyn Technical High School, Brooklyn, New York (1996-98)

Related Practices
Related Industries
Related Regions